"Current understanding of the human microbiome reports that it drives our immunity, metabolism, and overall health. As we begin to collect data on what’s really happening in our collective microbiota, then we can personalize that to develop strategies to optimize health." -Dr. Liz Lipski
SAN FRANCISCO (PRWEB) October 12, 2018
uBiome, the leader in microbial genomics, announces the addition of Dr. Liz Lipski, PhD, CNS, LDN, FACN, BCHN, Professor of Clinical Nutrition and Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health, and founder of Integrative Healing Inc., to its Scientific Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Lipski will bring to uBiome 30 years of experience in integrative nutrition and functional health education. The appointment will help uBiome continue its advancement in human microbiome research.
“Dr. Lipski’s 30 plus years of expertise in integrative nutrition and digestive health will be a great asset to our advisory board,” Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. “Her goal of expanding nutrition and GI education aligns with our goal of empowering people to take a more active role in their health.”
Dr. Lipski’s mission is to play a part in bringing nutrition, food, and lifestyle into the center of medicine by mentoring clinicians and training new nutrition professionals. She is an educator at the Institute for Functional Medicine and the Metabolic Medicine Institute and serves on the boards for the Accreditation Council for Nutrition Professional Education, Autism Hope Alliance, and Certified International Health Coaches. She is published in peer-reviewed journals and is the author of four books on digestive health, including, “Digestive Wellness.” In addition, she co-authored the gastrointestinal chapter for the American Board of Integrative Health and Medicine on study guide, and was a contributing author to “Integrative Gastroenterology.”
About joining uBiome's Scientific Advisory Board, Dr. Lipski said, “Current understanding of the human microbiome reports that it drives our immunity, metabolism, and overall health. As we begin to collect data on what’s really happening in our collective microbiota, then we can personalize that to develop strategies to optimize health. uBiome is on the forefront of this quest. I’m happy to be a small part of this revolution.”
In addition to Dr. Lipski, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company’s Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children’s Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets.
uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.